SCHEMBL5049381

SCHEMBL5049381

CC(C)(C)OC(=O)COc1cccc(CNCc2ccc(-c3ccncc3)cc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 9/20 0.53
ROCK1 Q13464 9/20 0.53
CYP3A4 P08684 4/20 0.53
CYP2D6 P10635 4/20 0.53
CYP2C9 P11712 4/20 0.53
PRKACA P17612 2/20 0.49
PRKX P51817 2/20 0.49
PRKCQ Q04759 2/20 0.49
GSK3A P49840 1/20 0.49
GSK3B P49841 1/20 0.49
CLK4 Q9HAZ1 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
MEN1 O00255 1/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
AURKA O14965 1/20 0.45
KDM4E B2RXH2 1/20 0.44
GRK5 P34947 1/20 0.44
HDAC1 Q13547 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5046403 0.90 KDM4E (0.51) ROCK2ROCK1CYP3A4CYP2D6CYP2C9
SCHEMBL5048113 0.90 SMN1; SMN2 (0.45) ROCK2ROCK1CYP3A4CYP2D6CYP2C9
SCHEMBL5043264 0.89 SMN1; SMN2 (0.49) ROCK2ROCK1CYP3A4CYP2D6CYP2C9
SCHEMBL5050279 0.87 KDM4E (0.46) ROCK2ROCK1CYP3A4CYP2D6CYP2C9
SCHEMBL5046663 0.87 L3MBTL1 (0.45) SMN1; SMN2MEN1MAPK1HTTKMT2A
SCHEMBL5048180 0.86 ADRB2 (0.44) ROCK2ROCK1CYP3A4CYP2D6CYP2C9
SCHEMBL5049384 0.84 SMN1; SMN2 (0.50) SMN1; SMN2MEN1KMT2AKDM4EHDAC1
SCHEMBL5046565 0.82 MAPT (0.46) CYP3A4CYP2D6SMN1; SMN2MEN1MAPK1
SCHEMBL15876016 0.82 SMN1; SMN2 (0.45) SMN1; SMN2MEN1KMT2AHDAC1
SCHEMBL5046821 0.81 PTGER2 (0.48) SMN1; SMN2KDM4EHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442702-B2 Treatment of bone disorders; carboxy derivatives PFIZER INC. (US) 2008-10-28 US disclosed
EP-1021410-B1 PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS PFIZER (US) 2006-12-27 EP disclosed
US-6498172-B1 (3-(((4-TERT-BUTYL-BENZYL)-(PYRIDINE-3-SULFONYL)-AMINO)-METHYL) -PHENOXY)-ACETIC ACID OR SALT; TREATING SUCH AS OSTEOPOROSIS PFIZER INC. 2002-12-24 US disclosed